730 related articles for article (PubMed ID: 21844547)
1. Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.
Wang C; Cao B; Liu QQ; Zou ZQ; Liang ZA; Gu L; Dong JP; Liang LR; Li XW; Hu K; He XS; Sun YH; An Y; Yang T; Cao ZX; Guo YM; Wen XM; Wang YG; Liu YL; Jiang LD
Ann Intern Med; 2011 Aug; 155(4):217-25. PubMed ID: 21844547
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.
Cao B; Li XW; Mao Y; Wang J; Lu HZ; Chen YS; Liang ZA; Liang L; Zhang SJ; Zhang B; Gu L; Lu LH; Wang DY; Wang C;
N Engl J Med; 2009 Dec; 361(26):2507-17. PubMed ID: 20007555
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
Fry AM; Goswami D; Nahar K; Sharmin AT; Rahman M; Gubareva L; Azim T; Bresee J; Luby SP; Brooks WA
Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590
[TBL] [Abstract][Full Text] [Related]
4. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial.
Duan ZP; Jia ZH; Zhang J; Liu S; Chen Y; Liang LC; Zhang CQ; Zhang Z; Sun Y; Zhang SQ; Wang YY; Wu YL
Chin Med J (Engl); 2011 Sep; 124(18):2925-33. PubMed ID: 22040504
[TBL] [Abstract][Full Text] [Related]
5. Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.
Ling LM; Chow AL; Lye DC; Tan AS; Krishnan P; Cui L; Win NN; Chan M; Lim PL; Lee CC; Leo YS
Clin Infect Dis; 2010 Apr; 50(7):963-9. PubMed ID: 20180701
[TBL] [Abstract][Full Text] [Related]
6. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
[TBL] [Abstract][Full Text] [Related]
7. [The clinical characteristics and treatment of community outbreaks of the new influenza A (H1N1) infection].
Wang P; Zhu ML; Song HJ; Xiao Q; Kong XC; Peng WH; Xing SL; Guo AM
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):419-21. PubMed ID: 20979812
[TBL] [Abstract][Full Text] [Related]
8. Antipyretic effect of Mao-to, a Japanese herbal medicine, for treatment of type A influenza infection in children.
Kubo T; Nishimura H
Phytomedicine; 2007 Feb; 14(2-3):96-101. PubMed ID: 17141491
[TBL] [Abstract][Full Text] [Related]
9. Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Kawai N; Ikematsu H; Hirotsu N; Maeda T; Kawashima T; Tanaka O; Yamauchi S; Kawamura K; Matsuura S; Nishimura M; Iwaki N; Kashiwagi S
Clin Infect Dis; 2009 Dec; 49(12):1828-35. PubMed ID: 19911968
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients.
Ison MG; Szakaly P; Shapira MY; Kriván G; Nist A; Dutkowski R
Antivir Ther; 2012; 17(6):955-64. PubMed ID: 22728756
[TBL] [Abstract][Full Text] [Related]
11. An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
Sert A; Yazar A; Odabas D; Bilgin H
Pediatr Pulmonol; 2010 Jul; 45(7):734-6. PubMed ID: 20575093
[TBL] [Abstract][Full Text] [Related]
12. Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) virus infections.
Escuret V; Cornu C; Boutitie F; Enouf V; Mosnier A; Bouscambert-Duchamp M; Gaillard S; Duval X; Blanchon T; Leport C; Gueyffier F; Van Der Werf S; Lina B
Antiviral Res; 2012 Nov; 96(2):130-7. PubMed ID: 22909899
[TBL] [Abstract][Full Text] [Related]
13. Survey of Japanese infants younger than 3 months who were treated with oseltamivir for influenza: safety of oseltamivir treatment.
Morioka I; Nonoyama S; Tanaka-Taya K; Ihara T; Sugaya N; Ueta I; Kumagai T; Okada K; Hosoya M; Okabe N; Morishima T;
Scand J Infect Dis; 2012 Aug; 44(8):605-9. PubMed ID: 22497443
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China.
Yu H; Liao Q; Yuan Y; Zhou L; Xiang N; Huai Y; Guo X; Zheng Y; van Doorn HR; Farrar J; Gao Z; Feng Z; Wang Y; Yang W
BMJ; 2010 Sep; 341():c4779. PubMed ID: 20876641
[TBL] [Abstract][Full Text] [Related]
15. Duration of viral shedding of influenza A (H1N1) virus infection treated with oseltamivir and/or traditional Chinese medicine in China: a retrospective analysis.
Wang YG; Jiang M; Wang RB; Zha QL; Zhang SJ; Zhou GQ; Li XW; Wang YY; Lv AP
J Tradit Chin Med; 2012 Jun; 32(2):148-55. PubMed ID: 22876436
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.
Lee VJ; Yap J; Cook AR; Chen MI; Tay JK; Tan BH; Loh JP; Chew SW; Koh WH; Lin R; Cui L; Lee CW; Sung WK; Wong CW; Hibberd ML; Kang WL; Seet B; Tambyah PA
N Engl J Med; 2010 Jun; 362(23):2166-74. PubMed ID: 20558367
[TBL] [Abstract][Full Text] [Related]
17. Viral shedding in Chinese young adults with mild 2009 H1N1 influenza.
Jia N; Gao Y; Suo JJ; Xie LJ; Yan ZQ; Xing YB; He L; Liu YX
Chin Med J (Engl); 2011 May; 124(10):1576-9. PubMed ID: 21740820
[TBL] [Abstract][Full Text] [Related]
18. Delayed oseltamivir treatment is associated with longer viral shedding of pandemic (H1N1) 2009 virus.
Leung YH; Lim WL; Wong MH; Chuang SK
Epidemiol Infect; 2012 May; 140(5):814-7. PubMed ID: 21801465
[TBL] [Abstract][Full Text] [Related]
19. The clinical effectiveness of oseltamivir in mild cases of pandemic influenza A H1N1 2009 infection.
Lee JS; Park SY; Kim JS; You JY; Ju YS; Eom JS
Scand J Infect Dis; 2012 Aug; 44(8):595-9. PubMed ID: 22497285
[TBL] [Abstract][Full Text] [Related]
20. Pathway Pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with maxingshigan-yinqiaosan formula.
Dai W; Chen J; Lu P; Gao Y; Chen L; Liu X; Song J; Xu H; Chen D; Yang Y; Yang H; Huang L
Mol Biosyst; 2013 Mar; 9(3):375-85. PubMed ID: 23348248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
